Biovica, active in cancer diagnostics, announces that FDA has granted 510 clearance for the product DiviTum®TKa as an aid in monitoring disease progression in previously diagnosed hormone receptor positive, metastatic postmenopausal female breast cancer patients.
July 30, 2022
· 2 min read